nach oben

Endocrine

Erschienen in:

27.12.2022 | Viewpoint

Looking at the spine in controlled Acromegaly

verfasst von: Maria Francesca Birtolo, Simone Antonini, Andrea G. Lania, Gherardo Mazziotti

Erschienen in: Endocrine | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Skeletal fragility with high risk of vertebral fractures (VFs) is an emerging complication of growth hormone (GH) hypersecretion. VFs often coexist with spine arthropathy and both clinical conditions negatively impact on quality of life of acromegalic subjects. Management of spine osteopathy and arthropathy in acromegaly could be challenging since both complications can persist or even progress after biochemical control of disease. This article analyzes the latest evidence about possible pathophysiological links between VFs and spine arthropathy in active and controlled acromegaly, as well as the diagnostic and therapeutic aspects concerning the holistic management of acromegalic osteo-arthropathy.

M. Fleseriu, A. Barkan, M. Del Pilar Schneider, Y. Darhi, A. de Pierrefeu, A. Ribeiro-Oliveira Jr., S. Petersenn, S. Neggers, S. Melmed, Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25(2), 296–307 (2022). https://doi.org/10.1007/s11102-021-01198-5CrossRef

M.D. Whittington, K.A. Munoz, J.D. Whalen, A. Ribeiro-Oliveira, J.D. Campbell, Economic and clinical burden of comorbidities among patients with acromegaly. Growth Horm. IGF Res.: Off. J. Growth Horm. Res. Soc. Int. IGF Res. Soc. 59, 101389 (2021). https://doi.org/10.1016/j.ghir.2021.101389CrossRef

I.C.M. Pelsma, N.R. Biermasz, W.R. van Furth, A.M. Pereira, H.M. Kroon, M. Kloppenburg, K. Claessen, Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9 years of longitudinal follow-up. J. Clin. Endocrinol. Metab. 106(1), 188–200 (2021). https://doi.org/10.1210/clinem/dgaa747CrossRef

I.C.M. Pelsma, H.M. Kroon, V.R. van Trigt, A.M. Pereira, M. Kloppenburg, N.R. Biermasz, K. Claessen, Clinical and radiographic assessment of peripheral joints in controlled acromegaly. Pituitary 25(4), 622–635 (2022). https://doi.org/10.1007/s11102-022-01233-zCrossRef

B. Cangiano, E. Giusti, C. Premoli, D. Soranna, G. Vitale, S. Grottoli, V. Cambria, G. Mantovani, R. Mungari, P. Maffei, F. Dassie, A. Giampietro, S. Chiloiro, M.L. Tanda, S. Ippolito, S. Cannavò, M. Ragonese, A. Zambon, L. Persani, L.M. Fatti, M. Scacchi, Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life. Endocrine 77(3), 510–518 (2022). https://doi.org/10.1007/s12020-022-03106-8CrossRef

G. Mazziotti, A.G. Lania, E. Canalis, Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis. Nat. Rev. Endocrinol. 18(6), 353–365 (2022). https://doi.org/10.1038/s41574-022-00649-8CrossRef

P. Vestergaard, L. Mosekilde, Fracture risk is decreased in acromegaly–a potential beneficial effect of growth hormone. Osteoporos. Int.: J. Est. Result Cooperation Eur. Found. Osteoporos. Natl Osteoporos. Found. USA 15(2), 155–159 (2004). https://doi.org/10.1007/s00198-003-1531-zCrossRef

C. Ribeiro de Moura, S. Campos Lopes, A.M. Monteiro (2022) Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis. Pituitary. https://doi.org/10.1007/s11102-022-01256-6

L. Dalle Carbonare, V. Micheletti, E. Cosaro, M.T. Valenti, M. Mottes, G. Francia, M.V. Davì, Bone histomorphometry in acromegaly patients with fragility vertebral fractures. Pituitary 21(1), 56–64 (2018). https://doi.org/10.1007/s11102-017-0847-1CrossRef

10.

M. Kužma, P. Vaňuga, I. Ságová, D. Pávai, P. Jackuliak, Z. Killinger, N. Binkley, R. Winzenrieth, J. Payer, Vertebral Fractures Occur Despite Control of Acromegaly and Are Predicted by Cortical Volumetric Bone Mineral Density. J. Clin. Endocrinol. Metab. 106(12), e5088–e5096 (2021). https://doi.org/10.1210/clinem/dgab259CrossRef

11.

F. Malgo, N.A.T. Hamdy, T.J. Rabelink, H.M. Kroon, K. Claessen, A.M. Pereira, N.R. Biermasz, N.M. Appelman-Dijkstra, Bone material strength index as measured by impact microindentation is altered in patients with acromegaly. Eur. J. Endocrinol. 176(3), 339–347 (2017). https://doi.org/10.1530/eje-16-0808CrossRef

12.

K. Godang, N.C. Olarescu, J. Bollerslev, A. Heck, Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study. Eur. J. Endocrinol. 175(2), 155–164 (2016). https://doi.org/10.1530/eje-16-0340CrossRef

13.

K. Godang, T. Lekva, K.R. Normann, N.C. Olarescu, K.A.B. Øystese, A. Kolnes, T. Ueland, J. Bollerslev, A. Heck, Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study. JBMR 3(12), e10240 (2019). https://doi.org/10.1002/jbm4.10240CrossRef

14.

L. Duan, S. Yang, L.J. Wang, Y. Zhang, R. Li, H. Yang, Y. Zhao, H. Du, X. Zhai, F. Gong, H. Pan, H. Zhu, W. Xia, The Negative Impacts of Acromegaly on Bone Microstructure Not Fully Reversible. Front. Endocrinol. 12, 738895 (2021). https://doi.org/10.3389/fendo.2021.738895CrossRef

15.

I.C.M. Pelsma, N.R. Biermasz, A.M. Pereira, W.R. van Furth, N.M. Appelman-Dijkstra, M. Kloppenburg, H.M. Kroon, K. Claessen, Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study. Eur. J. Endocrinol. 183(4), 427–437 (2020). https://doi.org/10.1530/eje-20-0415CrossRef

16.

G. Mazziotti, A. Bianchi, T. Porcelli, M. Mormando, F. Maffezzoni, A. Cristiano, A. Giampietro, L. De Marinis, A. Giustina, Vertebral fractures in patients with acromegaly: a 3-year prospective study. J. Clin. Endocrinol. Metab. 98(8), 3402–3410 (2013). https://doi.org/10.1210/jc.2013-1460CrossRef

17.

M.T. Valenti, M. Mottes, S. Cheri, M. Deiana, V. Micheletti, E. Cosaro, M.V. Davì, G. Francia, L. Dalle Carbonare, Runx2 overexpression compromises bone quality in acromegalic patients. Endocr.-Relat. Cancer 25(3), 269–277 (2018). https://doi.org/10.1530/erc-17-0523CrossRef

18.

E. Valassi, N. García-Giralt, J. Malouf, I. Crespo, J. Llauger, A. Díez-Pérez, S.M. Webb, Circulating miR-103a-3p and miR-660-5p are associated with bone parameters in patients with controlled acromegaly. Endocr. Connect. 8(1), 39–49 (2019). https://doi.org/10.1530/ec-18-0482CrossRef

19.

K. Claessen, I.C.M. Pelsma, H.M. Kroon, A.H. van Lierop, A.M. Pereira, N.R. Biermasz, N.M. Appelman-Dijkstra, Low sclerostin levels after long-term remission of acromegaly. Endocrine 75(1), 228–238 (2022). https://doi.org/10.1007/s12020-021-02850-7CrossRef

20.

E. Vitali, E. Palagano, M.L. Schiavone, G. Mantovani, C. Sobacchi, G. Mazziotti, A. Lania, Direct effects of octreotide on osteoblast cell proliferation and function. J. Endocrinol. Investig. 45(5), 1045–1057 (2022). https://doi.org/10.1007/s40618-022-01740-7CrossRef

21.

M.M. Uygur, D.D. Yazıcı, O. Buğdaycı, D.G. Yavuz, Prevalence of vertebral fractures and serum sclerostin levels in acromegaly. Endocrine 73(3), 667–673 (2021). https://doi.org/10.1007/s12020-021-02751-9CrossRef

22.

S. Chiloiro, A. Giampietro, S. Frara, C. Bima, F. Donfrancesco, C.M. Fleseriu, A. Pontecorvi, A. Giustina, M. Fleseriu, L. De Marinis, A. Bianchi, Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. J. Clin. Endocrinol. Metab. 105 (3) (2020). https://doi.org/10.1210/clinem/dgz054

23.

Z. Belaya, T. Grebennikova, G. Melnichenko, A. Nikitin, A. Solodovnikov, O. Brovkina, A. Grigoriev, L. Rozhinskaya, A. Lutsenko, I. Dedov, Effects of active acromegaly on bone mRNA and microRNA expression patterns. Eur. J. Endocrinol. 178(4), 353–364 (2018). https://doi.org/10.1530/eje-17-0772CrossRef

24.

M. Cellini, E. Biamonte, M. Mazza, N. Trenti, P. Ragucci, D. Milani, E. Ferrante, Z. Rossini, E. Lavezzi, E. Sala, G. Mantovani, M. Arosio, M. Fornari, L. Balzarini, A.G. Lania, G. Mazziotti, Vertebral Fractures Associated with Spinal Sagittal Imbalance and Quality of Life in Acromegaly: A Radiographic Study with EOS 2D/3D Technology. Neuroendocrinology 111(8), 775–785 (2021). https://doi.org/10.1159/000511811CrossRef

25.

G. Mazziotti, A.G.A. Lania, E. Canalis, Management of endocrine disease: Bone disorders associated with acromegaly: mechanisms and treatment. Eur. J. Endocrinol. 181(2), R45–r56 (2019). https://doi.org/10.1530/eje-19-0184CrossRef

26.

S. Frara, M. Melin Uygur, L. di Filippo, M. Doga, M. Losa, S. Santoro, P. Mortini, A. Giustina, High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly. J. Clin. Endocrinol. Metab. 107(7), e2843–e2850 (2022). https://doi.org/10.1210/clinem/dgac183CrossRef

27.

E. Melhem, A. Assi, R. El Rachkidi, I. Ghanem, EOS(®) biplanar X-ray imaging: concept, developments, benefits, and limitations. J. Children’s Orthop. 10(1), 1–14 (2016). https://doi.org/10.1007/s11832-016-0713-0CrossRef

28.

B. de Azevedo Oliveira, B. Araujo, T.M. Dos Santos, B.R. Ongaratti, C. Rech, N.P. Ferreira, J.F.S. Pereira-Lima, M. da Costa Oliveira, The acromegalic spine: fractures, deformities and spinopelvic balance. Pituitary 22(6), 601–606 (2019). https://doi.org/10.1007/s11102-019-00991-7CrossRef

29.

R.L. Prince, J.R. Lewis, W.H. Lim, G. Wong, K.E. Wilson, B.C. Khoo, K. Zhu, D.P. Kiel, J.T. Schousboe, Adding Lateral Spine Imaging for Vertebral Fractures to Densitometric Screening: Improving Ascertainment of Patients at High Risk of Incident Osteoporotic Fractures. J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res. 34(2), 282–289 (2019). https://doi.org/10.1002/jbmr.3595CrossRef

30.

K.M. Claessen, H.M. Kroon, A.M. Pereira, N.M. Appelman-Dijkstra, M.J. Verstegen, M. Kloppenburg, N.A. Hamdy, N.R. Biermasz, Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J. Clin. Endocrinol. Metab. 98(12), 4808–4815 (2013). https://doi.org/10.1210/jc.2013-2695CrossRef

31.

G. Mazziotti, C. Battista, F. Maffezzoni, S. Chiloiro, E. Ferrante, N. Prencipe, L. Grasso, F. Gatto, R. Olivetti, M. Arosio, M. Barale, A. Bianchi, M. Cellini, I. Chiodini, L. De Marinis, G. Del Sindaco, C. Di Somma, A. Ferlin, E. Ghigo, A. Giampietro, S. Grottoli, E. Lavezzi, G. Mantovani, E. Morenghi, R. Pivonello, T. Porcelli, M. Procopio, F. Pugliese, A. Scillitani, A.G. Lania, Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study. J. Clin. Endocrinol. Metab. 105 (9) (2020). https://doi.org/10.1210/clinem/dgaa363

32.

L.M. Fatti, B. Cangiano, G. Vitale, L. Persani, G. Mantovani, E. Sala, M. Arosio, P. Maffei, F. Dassie, M. Mormando, A. Giampietro, L. Tanda, E.R. Masiello, E. Nazzari, D. Ferone, S. Corbetta, E. Passeri, F. Guaraldi, S. Grottoli, S. Cannavò, M.L.T. Torre, D. Soranna, A. Zambon, F. Cavagnini, M. Scacchi, Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity. Pituitary 22(5), 552–560 (2019). https://doi.org/10.1007/s11102-019-00966-8CrossRef

33.

V.R. van Trigt, I.C.M. Pelsma, H.M. Kroon, A.M. Pereira, C. van der Meulen, M. Kloppenburg, N.R. Biermasz, K. Claessen, Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly. Pituitary 25(2), 229–237 (2022). https://doi.org/10.1007/s11102-021-01190-zCrossRef

Titel: Looking at the spine in controlled Acromegaly
verfasst von: Maria Francesca Birtolo
Simone Antonini
Andrea G. Lania
Gherardo Mazziotti
Publikationsdatum: 27.12.2022
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2023
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-022-03258-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Ketogenic state improves testosterone serum levels—results from a systematic review and meta-analysis

COVID-19 and its treatments: lights and shadows on testicular function

The impact of near-infrared autofluorescence on postoperative hypoparathyroidism during total thyroidectomy: a case–control study

Transcriptome-wide association study identifies novel genes associated with bone mineral density and lean body mass in children

Novel IGFALS mutations with predicted pathogenetic effects by the analysis of AlphaFold structure